TRPV2 activation induces apoptotic cell death in human T24 bladder cancer cells: a potential therapeutic target for bladder cancer (Q39693316)

14 September 2017

title

TRPV2 activation induces apoptotic cell death in human T24 bladder cancer cells: a potential therapeutic target for bladder cancer (English)

1 reference

14 September 2017

0 references

1 reference

Takahiro Yamada

1

1 reference

14 September 2017

Takashi Ueda

2

1 reference

14 September 2017

Yasuhiro Shibata

3

1 reference

14 September 2017

Yosuke Ikegami

4

1 reference

14 September 2017

Masaki Saito

5

1 reference

14 September 2017

Yusuke Ishida

6

1 reference

14 September 2017

Shinya Ugawa

7

1 reference

14 September 2017

Kenjiro Kohri

8

1 reference

14 September 2017

Shoichi Shimada

9

1 reference

14 September 2017

language of work or name

English

0 references

publication date

23 May 2010

1 reference

14 September 2017

1 reference

14 September 2017

volume

76

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

509.e1-7

1 reference

14 September 2017

cites work

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.029

BCG immunotherapy of bladder cancer: 20 years on.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.029

Long-term mitomycin C instillation after transurethral resection of superficial bladder carcinoma: influence on recurrence, progression and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.029

7 January 2021

TRP channels in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.029

Transient receptor potential cation channels in disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.029

Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.029

Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.029

TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.029

Functional interaction between T2R taste receptors and G-protein alpha subunits expressed in taste receptor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.029

Differential localizations of the transient receptor potential channels TRPV4 and TRPV1 in the mouse urinary bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.029

TRPM8 activation suppresses cellular viability in human melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.029

A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.029

Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.029

Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.029

Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.029

Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.029

Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.029

Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.029

Capsaicin-induced apoptosis of glioma cells is mediated by TRPV1 vanilloid receptor and requires p38 MAPK activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.029

Cannabidiol--recent advances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.029

A capsaicin-receptor homologue with a high threshold for noxious heat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.029

Immunohistochemical localization of growth factor-regulated channel (GRC) in human tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.029

10.1016/J.UROLOGY.2010.03.029

7 January 2021

Identifiers

DOI

1 reference

14 September 2017

1 reference